|
Market Cap (17-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 16 November 2021, 8:17. The announcement is marked as price sensitive, and is 38 page(s) in length and 6.49MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.410% short sold according to ASIC data. It was ranked the 311th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Investor Presentation - November 2021 | 16 November 2021, 8:17 |
| Australian TGA Approves Illuccix for Prostate Cancer Imaging | 2 November 2021, 9:29 |
| Activities Report and App 4C - September 2021 quarter | 21 October 2021, 8:19 |
| Release of Shares from Voluntary Escrow | 21 October 2021, 8:19 |
You must be logged in to post a reply.
Telix Pharmaceuticals 